All Blogs

Sep 17, 2025

Point-of-care (POC) diagnostics have revolutionized healthcare by enabling rapid, on-site testing that delivers actionable results without the delays of traditional laboratory processes. For instance, over 1.5 billion POC tests are performed annually worldwide, ranging from portable blood glucose monitors to point-...

Sep 16, 2025

Lion TCR Secures Triple FDA Milestones for Chronic Hepatitis B with IND Clearance of TCR-T Therapy Lion TCR announced that the FDA has cleared its Investigational New Drug (IND) application for LioCyx-M004, authorizing the initiation of phase Ib/II clinical trials in patients with chronic hepatitis B (CHB). The ...

Sep 15, 2025

Neovascular age-related macular degeneration (nAMD or Wet AMD) is a progressive retinal condition and a primary cause of central vision loss among individuals over 60 years old. While it represents only 10–15% of overall AMD cases, it is responsible for nearly 90% of severe vision impairment linked to the disease. ...

Sep 11, 2025

ONWARD Medical Received CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe  On September 8, 2025, ONWARD Medical N.V., a leading neurotechnology company developing therapies to restore movement, function, and independence for individuals with spinal cord ...

Sep 10, 2025

Pathology—the discipline of diagnosing disease through tissue analysis, has long depended on glass slides and microscopes. Today, digital pathology is undergoing a remarkable shift, as whole-slide imaging (WSI) and artificial intelligence (AI) come together to streamline lab workflows, accelerate diagnoses, and enh...

Sep 09, 2025

NeuroNOS Secures FDA Orphan Drug Designation for BA-101 in Glioblastoma NeuroNOS, a biopharmaceutical company specializing in neurological disorders and neuro-oncology and a subsidiary of Beyond Air, announced that the FDA has granted Orphan Drug Designation (ODD) to its lead investigational therapy, BA-101, for...

Sep 08, 2025

The Unmet Need in Cholesterol Management Cardiovascular Diseases (CVDs) continue to be one of the leading causes of morbidity and mortality worldwide, primarily driven by underlying lipid disorders, including Hypercholesterolemia (familial and non-familial hypercholesterolemia), Dyslipidemia, Atherosclerotic Car...

Sep 12, 2025

COPD management has progressively centered on bronchodilator-based regimens, with Long-acting Muscarinic Antagonists (LAMAs) and Long-acting Beta-agonists (LABAs) forming the therapeutic core. Dual LAMA/LABA therapy is standard for moderate disease, while triple therapy with Inhaled Corticosteroids (ICS) is reserve...

Sep 05, 2025

The cardiovascular space has witnessed a surge in strategic collaborations and licensing deals as companies race to address the rising global burden of heart disease with next-generation therapies. Recent transactions reflect a sharpened focus on precision cardiology, novel protein targets, and RNA-based approaches...

Sep 03, 2025

Each year, cardiovascular diseases claim approximately 17.9 million lives globally, accounting for about one-third of all deaths, most due to heart attacks and strokes. Despite notable advancements in imaging and a growing cardiac diagnostics market, early detection of conditions like heart failure, atrial fibrilla...